Fundraising Fox
Nucleusrad
Palo Alto, US · Founded 2022 · 56 employees on LinkedIn · 3 known investors
Find your way into Nucleusrad
Sign up to see every warm intro you have to Nucleusrad
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nucleusrad team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nucleus RadioPharma develops and manufactures radiopharmaceutical products, with production facilities capable of scaling to hundreds of thousands of doses per year. It operates sites including a Minnesota location and Springhouse Innovation Park in Pennsylvania.
Founders & leadership
Investors · 3
How we know: OrbiMed's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$72.1M disclosed across 2 rounds · 2022–2023
▶$66.1MraisedApr 2024 · 12 investors · Other Health CareRule 506(b)
- Tyrell RiversDirector
- Mary Kate WoldDirector
- Michael RossiDirector
- Norman SharplessDirector
- Chris McDonaldDirector
- Manu NairDirector
- Justin ButlerDirector
- Charles ConroyExecutive Officer, Director
- Offering amount
- $66.1M
- Amount sold
- $66.1M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$6MraisedApr 2024 · 3 investors · Other Health CareRule 506(b)
- Charles ConroyExecutive Officer, Director
- Justin ButlerDirector
- Manu NairDirector
- Tyrell RiversDirector
- Norman SharplessDirector
- Michael RossiDirector
- Chris McDonaldDirector
- Mary Kate WoldDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Nucleusrad do?
- Nucleus RadioPharma develops and manufactures radiopharmaceutical products, with production facilities capable of scaling to hundreds of thousands of doses per year. It operates sites including a Minnesota location and Springhouse Innovation Park in Pennsylvania.
- Who are Nucleusrad's investors?
- Nucleusrad's investors include Eclipse, OrbiMed, Eclipse Ventures.
- How much funding has Nucleusrad raised?
- Nucleusrad has disclosed $72.1M raised across 2 rounds.
- Where is Nucleusrad headquartered?
- Nucleusrad is headquartered in Palo Alto, US.